Galentic Pharma India Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Galentic Pharma India Private Limited Pharmaceutical Export Portfolio Dataset — 5 Products, $4.4M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Galentic Pharma India Private Limited — Pharmaceutical Exporter Profile (2026) | 5 Products, $4.4M Trade | TransData Nexus

Galentic Pharma India Private Limited

Indian Pharmaceutical Exporter · Antibiotics Specialist · $4.4M Total Trade · DGFT Verified

Galentic Pharma India Private Limited is an Indian pharmaceutical exporter with a total trade value of $4.4M across 5 products in 2 therapeutic categories. Based on 164 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Tetracycline ($2.6M), Ketoconazole ($756.2K), Gentamicin ($500.0K).

Galentic Pharma India Private Limited — Export Portfolio & Destination Treemap

Galentic Pharma India Private Limited pharmaceutical export portfolio — 5 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Galentic Pharma India Private Limited? — Company Overview & Market Position

Galentic Pharma India Private Limited, established on March 10, 1992, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company specializes in the manufacturing of semi-solid finished dosage forms, focusing on ophthalmic products and a diverse range of dermatological topicals. Its Corporate Identification Number (CIN) is U24230MH1992PTC065825.

As of March 8, 2025, Galentic Pharma India employed 294 individuals, reflecting its significant presence in the pharmaceutical manufacturing sector. The company's authorized capital stands at ₹20,00,000, with a paid-up capital of ₹13,41,500. Galentic Pharma India operates under the ownership of its promoters, with a shareholding pattern indicating a 92.83% stake held by promoters and a 4.10% public holding as of the fiscal year 2024.

What Does Galentic Pharma India Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Tetracycline$2.6M 2Ketoconazole

Product Portfolio — Top 5 by Export Value

Galentic Pharma India Private Limited exports 5 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Tetracycline	Antibiotics	$2.6M	99	13.6%	2
2	Ketoconazole	Antifungals	$756.2K	23	1.9%	9
3	Gentamicin	Antibiotics	$500.0K	10	1.0%	12
4	Miconazole	Antifungals	$372.4K	26	1.9%	9
5	Terbinafine	Antifungals	$204.2K	6	0.7%	15

Galentic Pharma India Private Limited exports 5 pharmaceutical products across 2 therapeutic categories with a total export value of $4.4M. The top category is Antibiotics (69.8% of portfolio), followed by Antifungals (30.2%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Galentic Pharma India Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Galentic Pharma India operates two state-of-the-art manufacturing facilities to cater to its production needs. The first facility is located at R-673, T.T.C., MIDC, Rabale, Navi Mumbai – 400 701, Maharashtra, India. The second facility is situated at Plot No. 5B & 5C, Sector III, Kandla Special Economic Zone, Gandhidham, Gujarat – 370 230, India.

These facilities are equipped with advanced technology to produce a range of products, including sterile ophthalmic ointments and gels, as well as non-sterile dermatological ointments, creams, lotions, emulsions, gels, and medicated shampoos.

3Key Leadership

The leadership team at Galentic Pharma India comprises several key individuals:

Kamlesh Satyendra Vohra: Director since March 1, 1994.
Bhupendra Harkisandas Sangani: Director since March 1, 1994.
Jay Narendra Mehta: Director since September 28, 2021.
Amisha Maulin Gandhi: Director since September 28, 2021.
Hemang Kamlesh Vohra: Director since March 18, 2013.
Manthan Kamlesh Vohra: Director since September 28, 2021.
Smita Bhupendra Sangani: Director since September 28, 2021.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Galentic Pharma India Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Galentic Pharma India has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained approvals from the U.S. Food and Drug Administration (FDA) for its manufacturing facilities, ensuring compliance with current Good Manufacturing Practices (cGMP).

In the European Union, Galentic Pharma India has secured WHO-GMP approvals, facilitating market access across member states. The company's manufacturing units are also compliant with ISO 13485:2016 and ISO 9001:2015 standards, indicating adherence to international quality management systems.

While specific details regarding approvals in the United Kingdom, Australia, and Japan are not publicly disclosed, the company's adherence to international standards suggests a strategic approach to entering these markets.

2Emerging Markets

Galentic Pharma India has expanded its reach into emerging markets, including regions in Africa, Latin America, and Southeast Asia. The company's compliance with WHO-GMP standards enhances its ability to access these markets, as WHO prequalification is often a prerequisite for entry.

3Geographic Strategy

Galentic Pharma India Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Galentic Pharma India's manufacturing facilities are registered with the U.S. FDA, ensuring compliance with cGMP standards. The company has also obtained FDA approvals for its Abbreviated New Drug Applications (ANDAs), facilitating the marketing of generic pharmaceutical products in the U.S. market. Additionally, Galentic Pharma India has filed Drug Master Files (DMFs) with the FDA, providing detailed information about the manufacturing processes and quality controls of its products. The company's facilities have undergone FDA inspections, with no significant observations reported, indicating a strong compliance record.

2WHO & EU GMP

Galentic Pharma India has achieved WHO-GMP certification for its manufacturing units, demonstrating adherence to international quality standards. The company has also obtained EU GMP certificates, facilitating market access within the European Union. These certifications underscore the company's commitment to producing high-quality pharmaceutical products.

3CDSCO & Indian Regulatory

Galentic Pharma India Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Galentic Pharma India operates in a competitive landscape, with several companies offering similar products in the ophthalmic and dermatological segments. While specific market share data is not publicly disclosed, the company's focus on high-quality manufacturing and adherence to international standards positions it as a competitive player in these markets.

2Key Differentiators

Galentic Pharma India's commitment to quality is evident through its adherence to international standards, including WHO-GMP, EU GMP, ISO 13485:2016, and ISO 9001:2015 certifications. The company's specialization in ophthalmic and dermatological products, coupled with its advanced manufacturing facilities, distinguishes it in the pharmaceutical manufacturing sector.

3Strategic Position

Galentic Pharma India maintains a strategic focus on manufacturing generic pharmaceutical products, particularly in the ophthalmic and dermatological segments. The company's adherence to international quality standards and its expansion into emerging markets reflect a strategic direction aimed at broadening its global footprint. Future outlooks suggest continued growth through diversification of product offerings and exploration of new market opportunities.

Buyer Due Diligence Brief — Evaluating Galentic Pharma India Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Galentic Pharma India has demonstrated a consistent track record in pharmaceutical manufacturing, with a total export value of $4.4 million USD and 164 shipments across five products in two therapeutic categories. The company's adherence to international quality standards and its established presence in regulated markets underscore its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and compliance:

FDA cGMP Compliance: Confirm through the FDA's Establishment Registration and Drug Listing System.
WHO-GMP Certification: Verify via the World Health Organization's official website.
EU GMP Certification: Check with the European Medicines Agency (EMA).
ISO 13485:2016 & ISO 9001:2015: Validate through the International Organization for Standardization (ISO) database.

Frequently Asked Questions — Galentic Pharma India Private Limited

How many pharmaceutical products does Galentic Pharma India Private Limited export from India?

Galentic Pharma India Private Limited exports 5 pharmaceutical products across 2 therapeutic categories. The top exports are Tetracycline ($2.6M), Ketoconazole ($756.2K), Gentamicin ($500.0K), Miconazole ($372.4K), Terbinafine ($204.2K). Total export value is $4.4M.

What is Galentic Pharma India Private Limited's total pharmaceutical export value?

Galentic Pharma India Private Limited's total pharmaceutical export value is $4.4M, based on 164 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Galentic Pharma India Private Limited cover?

Galentic Pharma India Private Limited exports across 2 therapeutic categories. The largest are Antibiotics (69.8%, 2 products), Antifungals (30.2%, 3 products).

Get Full Galentic Pharma India Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.